PDA

View Full Version : Study results strengthen the case for using Regeneron’s antibody cocktail in high-risk Covid patients.

news
03-23-2021, 04:08 PM
The treatment sharply cut the risk of hospitalization and death in a large clinical trial, the drug maker announced.

More... (https://www.nytimes.com/2021/03/22/world/regeneron-monoclonal-antibodies-covid.html)